Gossamer Bio

$8.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 3:55 PM UTC today

Why Robinhood?

You can buy or sell Gossamer Bio and other stocks, options, and ETFs commission-free!

About GOSS

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 25, 2015 and is headquartered in San Diego, CA. The listed name for GOSS is Gossamer Bio, Inc. Common Stock.

CEO
Faheem Hasnain
Employees
171
Headquarters
San Diego, California
Founded
2015
Market Cap
665.13M
Price-Earnings Ratio
Dividend Yield
Average Volume
520.29K
High Today
$8.98
Low Today
$8.73
Open Price
$8.93
Volume
80.35K
52 Week High
$27.15
52 Week Low
$7.52

Collections

GOSS Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.85 per share
Actual
-$0.80 per share

You May Also Like